You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PSMA therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

Not yet recruiting
  • Cancer
  • [177Lu]Lu-PSMA I&T
  • Meldola, Forlì, Italy
  • +1 more
May 10, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 8, 2023

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)

Not yet recruiting
  • Patients With Metastatic Castration-resistant Prostate Cancer
  • 177Lu-PSMA-617 PET scan
  • (no location specified)
Nov 13, 2023

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy

Enrolling by invitation
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023

Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radionuclide Therapy
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jun 5, 2023

Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • 225^Ac-PSMA-617
  • 68^Ga-PSMA-11
  • Darlinghurst, Australia
  • +1 more
Nov 23, 2022

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)

Not yet recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Biospecimen Collection
  • +6 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 25, 2023

Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Grand Rapids (SPECT/CT)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • SPECT/CT
  • Grand Rapids, Michigan
    BAMF Health
Apr 19, 2023

Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)

Recruiting
  • Prostate Cancer
  • PSMA-Targeted [In-111]-Labeled Trillium Compound
  • PTI-122
  • Glen Burnie, Maryland
  • +2 more
Mar 21, 2023

Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

Recruiting
  • Salivary Gland Cancer
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 27, 2022

Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))

Not yet recruiting
  • Prostate Cancer
  • Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
  • (no location specified)
Jan 26, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Castration Sensitive Prostate Cancer
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 16, 2023

Prostate Cancer Trial (Radiopharmaceutical 68Ga-PSMA-11 PET/CT)

Not yet recruiting
  • Prostate Cancer
  • Radiopharmaceutical 68Ga-PSMA-11 PET/CT
  • (no location specified)
Oct 12, 2022

Solid Tumor Trial in Shenzhen (bi-4SCAR GD2/PSMA T cells)

Recruiting
  • Solid Tumor
  • bi-4SCAR GD2/PSMA T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 25, 2022

Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los

Terminated
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022

Cancer Disease Trial in Shenzhen (bi-4SCAR PSMA/CD70 T cells)

Recruiting
  • Cancer Disease
  • bi-4SCAR PSMA/CD70 T cells
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Jun 25, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

Recruiting
  • Salivary Gland Cancer
  • Salivary Duct Carcinoma
  • 68Ga-PSMA-PET/CT
  • 18FDG-PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 15, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

Active, not recruiting
  • Prostate Cancer
  • +5 more
  • 131I-PSMA-1095 Radioligand Therapy (RLT)
  • Montreal, Quebec, Canada
    Stephan Probst
Oct 24, 2022

Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

Not yet recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Weill Cornell Medicine - New York Presbyterian Hospital
Oct 3, 2022

Hepatocellular Carcinoma Trial in Rochester (Ga-68 labeled PSMA-11, Possible liver biopsy for locoregional therapy group)

Recruiting
  • Hepatocellular Carcinoma
  • Ga-68 labeled PSMA-11
  • Possible liver biopsy for locoregional therapy group
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 18, 2022